The aim of this project is to study further the involvement of adenosine derivatives in the function of cholinergic nerve endings in the peripheral nervous system. With respect to the release of adenine nucleotide, is there an association between all forms of acetylcholine (ACh) secretion and the release of adenosine triphosphate (ATP). Specifically, ACh release will be evoked by various methods and the release of ATP and ACh assayed. Bioassay chemical methods will be used to detect ACh release and the firefly bioluminescence reaction employed to detect ATP release. With respect to the effects of adenosine derivatives, an electrophysiological study of ACh release will be made to characterize the specific adenosine receptors that mediate inhibition and enhancement of ACh release at motor nerve endings and the putative adenosine phosphate receptors that inhibit ACh release at preganglionic nerve endings. The potency sequences for various agonists and antagonists and the relationship between adenosine or purinergic receptor activation and intracellular modulators such as Ca and cyclic necleotides will be investigated. Liposomes will be employed as a means of delivering Ca or purine derivatives to the cytoplasm of the nerve ending. As abnormal adenine necleotide metabolism occurs in certain forms of muscle disease (e.g. Duchenne dystrophy), and ACh release is impaired at ganglia in familial dysautonomia, studying the normal relationship between adenosine derivatives and neuromuscular function should provide a valuable framework for future studies on the diseased cholinergic synapses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS012782-08
Application #
3394982
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1979-05-01
Project End
1989-11-30
Budget Start
1985-12-01
Budget End
1986-11-30
Support Year
8
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
School of Medicine & Dentistry
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Silinsky, Eugene M (2013) Low-frequency neuromuscular depression is a consequence of a reduction in nerve terminal Ca2+ currents at mammalian motor nerve endings. Anesthesiology 119:326-34
Searl, Timothy J; Silinsky, Eugene M (2012) Evidence for constitutively-active adenosine receptors at mammalian motor nerve endings. Eur J Pharmacol 685:38-41
Searl, T J; Silinsky, E M (2012) Modulation of purinergic neuromuscular transmission by phorbol dibutyrate is independent of protein kinase C in murine urinary bladder. J Pharmacol Exp Ther 342:312-7
Searl, Timothy J; Silinsky, Eugene M (2008) Mechanisms of neuromodulation as dissected using Sr2+ at motor nerve endings. J Neurophysiol 99:2779-88
Silinsky, Eugene M (2008) Selective disruption of the mammalian secretory apparatus enhances or eliminates calcium current modulation in nerve endings. Proc Natl Acad Sci U S A 105:6427-32
Searl, Timothy J; Silinsky, Eugene M (2005) Modulation of Ca(2+)-dependent and Ca(2+)-independent miniature endplate potentials by phorbol ester and adenosine in frog. Br J Pharmacol 145:954-62
Silinsky, Eugene M (2005) Modulation of calcium currents is eliminated after cleavage of a strategic component of the mammalian secretory apparatus. J Physiol 566:681-8
Silinsky, Eugene M (2004) Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction. J Physiol 558:389-401
Searl, T J; Silinsky, E M (2003) Phorbol esters and adenosine affect the readily releasable neurotransmitter pool by different mechanisms at amphibian motor nerve endings. J Physiol 553:445-56
Hirsh, Jody K; Searl, Timothy J; Silinsky, Eugene M (2002) Regulation by Rab3A of an endogenous modulator of neurotransmitter release at mouse motor nerve endings. J Physiol 545:337-43

Showing the most recent 10 out of 35 publications